Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;6(9):e005427.
doi: 10.1136/bmjgh-2021-005427.

Characterising long COVID: a living systematic review

Melina Michelen  1   2 , Lakshmi Manoharan #  2 , Natalie Elkheir #  3 , Vincent Cheng #  4 , Andrew Dagens #  2 , Claire Hastie  5 , Margaret O'Hara  5 , Jake Suett  6 , Dania Dahmash  2 , Polina Bugaeva  7 , Ishmeala Rigby  2 , Daniel Munblit  8   9   10 , Eli Harriss  11 , Amanda Burls  1 , Carole Foote  12 , Janet Scott  13 , Gail Carson  2 , Piero Olliaro  2 , Louise Sigfrid  2 , Charitini Stavropoulou  14
Affiliations

Characterising long COVID: a living systematic review

Melina Michelen et al. BMJ Glob Health. 2021 Sep.

Abstract

Background: While it is now apparent clinical sequelae (long COVID) may persist after acute COVID-19, their nature, frequency and aetiology are poorly characterised. This study aims to regularly synthesise evidence on long COVID characteristics, to help inform clinical management, rehabilitation strategies and interventional studies to improve long-term outcomes.

Methods: A living systematic review. Medline, CINAHL (EBSCO), Global Health (Ovid), WHO Global Research on COVID-19 database, LitCovid and Google Scholar were searched till 17 March 2021. Studies including at least 100 people with confirmed or clinically suspected COVID-19 at 12 weeks or more post onset were included. Risk of bias was assessed using the tool produced by Hoy et al. Results were analysed using descriptive statistics and meta-analyses to estimate prevalence.

Results: A total of 39 studies were included: 32 cohort, 6 cross-sectional and 1 case-control. Most showed high or moderate risk of bias. None were set in low-income countries and few included children. Studies reported on 10 951 people (48% female) in 12 countries. Most included previously hospitalised people (78%, 8520/10 951). The longest mean follow-up time was 221.7 (SD: 10.9) days post COVID-19 onset. Over 60 physical and psychological signs and symptoms with wide prevalence were reported, most commonly weakness (41%; 95% CI 25% to 59%), general malaise (33%; 95% CI 15% to 57%), fatigue (31%; 95% CI 24% to 39%), concentration impairment (26%; 95% CI 21% to 32%) and breathlessness (25%; 95% CI 18% to 34%). 37% (95% CI 18% to 60%) of patients reported reduced quality of life; 26% (10/39) of studies presented evidence of reduced pulmonary function.

Conclusion: Long COVID is a complex condition with prolonged heterogeneous symptoms. The nature of studies precludes a precise case definition or risk evaluation. There is an urgent need for prospective, robust, standardised, controlled studies into aetiology, risk factors and biomarkers to characterise long COVID in different at-risk populations and settings.

Prospero registration number: CRD42020211131.

Keywords: COVID-19; public health; systematic review.

PubMed Disclaimer

Conflict of interest statement

Competing interests: JSuett declares he is an individual living with long-term symptoms of probably COVID-19. All other authors declare no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1
Map of study distribution.
Figure 2
Figure 2
Long COVID signs and symptoms.
Figure 3
Figure 3
Signs and symptoms in all studies. RoB, risk of bias.
Figure 4
Figure 4
Sign and symptoms in hospitalised and non-hospitalised cohorts. Note: The data on sign and symptoms from studies with data on hospitalised or non-hospitalised cohorts, it does not include studies that included mixed cohorts without subcategorisation. PTSD, post-traumatic stress disorder.
See this image and copyright information in PMC

References

    1. World Health Organization . Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 2020.
    1. ONS . The prevalence of long COVID symptoms and COVID-19 complications - Office for National Statistics, 2020. Available: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovi... [Accessed 14 Aug 2021].
    1. Callard F, Perego E. How and why patients made long Covid. Soc Sci Med 2021;268:113426. 10.1016/j.socscimed.2020.113426 - DOI - PMC - PubMed
    1. Nabavi N. Long covid: how to define it and how to manage it. BMJ 2020;370:m3489. 10.1136/bmj.m3489 - DOI - PubMed
    1. Greenhalgh T, Knight M, A'Court C, et al. . Management of post-acute covid-19 in primary care. BMJ 2020;370:m3026. 10.1136/bmj.m3026 - DOI - PubMed

Publication types